HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

Inclusion Criteria: * Patients with primary gynecological malignant tumor confirmed by histopathology * Women aged 18-75 * The expected survival time is greater than 12 weeks * KPS \> 60, ECOG score is 0-2 * All subjects voluntarily joined this study with informed consents, and had good compliance of follow-up Exclusion Criteria: * Pregnant and lactating women * Suffering from other malignant tumors in the past 5 years * Patients who are not suitable for this study according to the investigator's judgment